Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Denisa Miklankova"'
Publikováno v:
Journal of Diabetes Research.
Introduction. Monounsaturated fatty acids (MUFA) are understood to have therapeutic and preventive effects on chronic complications associated with type 2 diabetes mellitus (T2DM); however, there are differences between individual MUFAs. Although the
Autor:
Hana Malinska, Iveta Zapletalova, Martin Haluzik, Denisa Miklankova, Irena Markova, Martin Poruba, Martina Hüttl, Ivana Vaněčková
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 21
International Journal of Molecular Sciences, Vol 22, Iss 11513, p 11513 (2021)
Volume 22
Issue 21
International Journal of Molecular Sciences, Vol 22, Iss 11513, p 11513 (2021)
Recent studies suggest that treatment with SGLT-2 inhibitors can reduce hepatic lipid storage and ameliorate non-alcoholic fatty liver disease (NAFLD) development beyond their glycemic benefits. However, the exact mechanism involved is still unclear.
Autor:
Denisa Miklankova, Jaroslava Trnovska, Irena Markova, Martin Poruba, Hana Malinska, Martina Hüttl, Iveta Zapletalova
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 9
International Journal of Molecular Sciences, Vol 22, Iss 4527, p 4527 (2021)
Volume 22
Issue 9
International Journal of Molecular Sciences, Vol 22, Iss 4527, p 4527 (2021)
Ovarian hormone deficiency leads to increased body weight, visceral adiposity, fatty liver and disorders associated with menopausal metabolic syndrome. To better understand the underlying mechanisms of these disorders in their early phases of develop
Autor:
Jan Pitha, Martina Huttl, Hana Malinska, Denisa Miklankova, Hana Bartuskova, Tomas Hlinka, Irena Markova
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 5; Pages: 2825
Background: If menopause is really independent risk factor for cardiovascular disease is still under debate. We studied if ovariectomy in the model of insulin resistance causes cardiovascular changes, to what extent are these changes reversible by es
Autor:
Iveta Zapletalova, Martina Hüttl, Denisa Miklankova, Hana Malinska, Martin Poruba, Irena Markova
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 14
International Journal of Molecular Sciences, Vol 22, Iss 7680, p 7680 (2021)
Volume 22
Issue 14
International Journal of Molecular Sciences, Vol 22, Iss 7680, p 7680 (2021)
Metformin can reduce cardiovascular risk independent of glycemic control. The mechanisms behind its non-glycemic benefits, which include decreased energy intake, lower blood pressure and improved lipid and fatty acid metabolism, are not fully underst